Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: a systematic review and meta-analysis.
about
Methicillin-resistant Staphylococcus aureus nosocomial pneumonia: role of linezolid in the People's Republic of ChinaA comparative evaluation of adverse platelet outcomes among Veterans' Affairs patients receiving linezolid or vancomycin.Linezolid-induced thrombocytopenia in impaired renal function: is it time for a dose adjustment? A case report and review of literature.Treatment of hospital-acquired pneumonia with linezolid or vancomycin: a systematic review and meta-analysis.Comparative evaluation of thrombocytopenia in adult patients receiving linezolid or glycopeptides in a respiratory intensive care unit.Drug-induced thrombocytopenia in the critically ill: a case-control study.Linezolid versus vancomycin for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a systematic review employing meta-analysis.The Whole Price of Vancomycin: Toxicities, Troughs, and TimeHigh vancomycin minimum inhibitory concentration and clinical outcomes in adults with methicillin-resistant Staphylococcus aureus infections: a meta-analysis.The efficacy and safety of linezolid and glycopeptides in the treatment of Staphylococcus aureus infectionsThe Japanese guidelines for the management of sepsis.No Outbreak of Vancomycin and Linezolid Resistance in Staphylococcal Pneumonia over a 10-Year Period.Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society.Guidelines for diagnosis and management of community- and hospital-acquired pneumonia in adults: Joint ICS/NCCP(I) recommendations.Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) pneumonia: linezolid or vancomycin? - Comparison of pharmacology and clinical efficacy.Telavancin for the treatment of serious gram-positive infections, including hospital acquired pneumonia.Telavancin for the treatment of hospital-acquired pneumonia: findings from the ATTAIN studies.Management and prevention of ventilator-associated pneumonia caused by multidrug-resistant pathogens.Pharmacotherapy for methicillin-resistant Staphylococcus aureus nosocomial pneumonia.The pharmacokinetics and pharmacodynamics of vancomycin in clinical practice: evidence and uncertainties.An evidence-based review of linezolid for the treatment of methicillin-resistant Staphylococcus aureus (MRSA): place in therapy.Renin-angiotensin system inhibitors for prevention of recurrent atrial fibrillation: a meta-analysis.Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: meta-analysis of randomised controlled trials.Addition of rifampin to vancomycin for methicillin-resistant Staphylococcus aureus infections: what is the evidence?Treating paediatric community-acquired pneumonia in the era of antimicrobial resistance.Ventilator-associated pneumonia: present understanding and ongoing debates.Ventilator-Associated Pneumonia (VAP) with Multidrug-Resistant (MDR) Pathogens: Optimal Treatment?A 2015 Update on Ventilator-Associated Pneumonia: New Insights on Its Prevention, Diagnosis, and Treatment.PEGylated liposome encapsulation increases the lung tissue concentration of vancomycin.Linezolid for the treatment of hospital-acquired pneumonia in a Chinese tertiary hospitalManaging Severe Community-Acquired Pneumonia Due to Community Methicillin-Resistant Staphylococcus aureus (MRSA).Clinical Pharmacokinetics and Pharmacodynamics of Oxazolidinones.Linezolid: a review of its properties, function, and use in critical care.
P2860
Q26749179-31E4FAEC-0403-481B-9D3B-91440FC83F0AQ33398776-44319E4C-7396-47C8-AD68-533D8C91DDF6Q33410244-EB1D985F-D9A9-4524-979C-6F0DE4A21D0EQ33410942-67B5972C-6201-4664-B5E6-2F9EC3459639Q33412500-C359E904-96EB-4611-A561-889252ACFD35Q33414170-3B38F138-2B83-4BF1-8771-FC1E89FF0FEDQ33418451-A32767BD-4B8B-4564-AF16-48275A11D5F7Q33885191-4F88BA89-8EEF-4A9E-91D8-89B31184F61FQ34454418-DE380AD8-94AB-4B31-93C7-8C67BDD74F0BQ34618696-04272DA4-2AEA-4890-B439-8C14978549EEQ35107094-C421866A-6B26-4CA2-A462-CB492EAB6DB3Q35785093-C5897BAB-475B-4130-9639-780106280DCBQ36078359-1B5CBE38-B709-48D4-8D72-118B023BAA22Q36281234-542208F5-6873-48D9-A01E-3EF3487DB33BQ37821604-D3925CF7-660C-4850-A792-EF71A073E28CQ37955286-36BBA6B7-FC03-4F04-A9D7-00879A3E6FA5Q38048845-1CE48EB5-29BE-40F6-999B-45A9F729A94EQ38058355-B87C774B-C360-4453-8CDD-9A1F5B0DACBDQ38066654-514AE414-426F-4494-BA09-FB59381DD90CQ38068293-7CA77F82-8537-43E9-B9DA-40259C08EE5DQ38070154-4AEAE0BE-C4A6-4F63-9F60-D26F7B4CCB4AQ38096077-F0A746E8-040C-4736-822F-F5F5C906CE81Q38097374-80E495F1-9ADF-4A19-9E12-7004F07C9B7FQ38110140-5C9BA94E-FAF5-49B1-8920-63C39300E4A1Q38170557-7199C8DB-24DB-4E70-9B80-9DCD07DFA387Q38271775-AC492ED6-AC07-4DD4-A9FA-39BAAC5B1ADDQ38532531-4F49BBA6-FE2D-41A0-BC76-DF876ED9F5DCQ38538710-8452147E-F738-4CCF-944A-1191DF3DD42DQ38627072-CF1D7424-3526-4DBA-90F5-F66966F2E1AEQ40914358-974B4A34-C849-4057-B18D-C392EC97127AQ43636170-95BC410E-F950-44BE-96F2-EE682645A2DAQ47611899-8D6E88AF-0CD7-4D42-9C00-E2F436B077D7Q55368160-632EFD2F-91C6-4644-9E25-96246F147B50
P2860
Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: a systematic review and meta-analysis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Linezolid versus vancomycin or ...... atic review and meta-analysis.
@ast
Linezolid versus vancomycin or ...... atic review and meta-analysis.
@en
type
label
Linezolid versus vancomycin or ...... atic review and meta-analysis.
@ast
Linezolid versus vancomycin or ...... atic review and meta-analysis.
@en
prefLabel
Linezolid versus vancomycin or ...... atic review and meta-analysis.
@ast
Linezolid versus vancomycin or ...... atic review and meta-analysis.
@en
P2093
P1476
Linezolid versus vancomycin or ...... atic review and meta-analysis.
@en
P2093
Andre C Kalil
Elizabeth D Hermsen
Felipe K Neto
Junfeng Sun
Madhu H Murthy
Mark E Rupp
P304
P356
10.1097/CCM.0B013E3181EB3B96
P407
P577
2010-09-01T00:00:00Z